David Millikin appointed North America Sales and Marketing Director
Brings long North America experience to developing AFP’s regional business.
Budapest (AFP) | 22/07/2026 - 14:25:39 | Hungary's Orban-era top prosecutor resigns
Tehran (AFP) | 22/07/2026 - 13:59:46 | Iran media reports US strike on Larak island in Hormuz
Manama (AFP) | 22/07/2026 - 13:44:03 | Sirens sound in Bahrain: interior ministry
Geneva (AFP) | 22/07/2026 - 13:34:36 | UN rights chief slams Nicaragua after threat to abolish elections
Berlin (AFP) | 22/07/2026 - 12:54:57 | Germany approves controversial French-Russian nuclear project: state ministry
Rome (AFP) | 22/07/2026 - 12:47:12 | Israel-Lebanon talks to be held in Italy on August 4: Italian FM
Paris (AFP) | 22/07/2026 - 12:27:52 | France's environment minister to stay given 'urgency' to act on climate: office
Geneva (AFP) | 22/07/2026 - 12:25:05 | Over 1,000 deaths recorded in Ebola outbreak in DRC, Uganda: WHO
London (AFP) | 22/07/2026 - 12:00:20 | Brent North Sea crude soars above $95 a barrel on Mideast war
Moscow (AFP) | 22/07/2026 - 11:31:45 | Kremlin says new Ukraine commander will not change situation at front
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and acces...
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and prop...
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an In...
Brings long North America experience to developing AFP’s regional business.
AV Access, a leading Pro AV provider, today introduced the AnyCo V100 all-in-one 4K conference video bar. Designed for small meeting spaces and huddle rooms, the AnyCo V100 streamlines hybrid work by combining video conferencing, presentation capabilities, 4K AI camera, speakerphones, laptop charging, and network connectivity into a single device. The product will be officially showcased at the InfoComm Asia 2026 exhibition starting tomorrow. One-Cable Plug-and-Play Video Conferencing and Pre...
Record Asset Management GmbH (RAM), subsidiary of London-listed Record plc (Record Financial Group), today announced that its Infrastructure Equity fund has attracted EUR 160 million of additional capital from Swiss pension funds, increasing total commitments to approximately EUR 1.23 billion. Capital deployment continues to progress in line with expectations, with more than one-third of the fund’s initial capital now deployed or committed to investments. This press release features multimedia...
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With establis...
We may collect the data listed below in connection with your use of the Platform. These data are not all considered to be "personal data" under applicable law. However, we want to provide you with the most comprehensive information on all the data we process when you use this Platform.